Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
With obesity comes risks such as type 2 diabetes, heart disease, stroke, cancer, sleep apnea, etc
In these STEP trials, most participants experienced mild to moderate symptoms, with the incidence of severe side effects being 9.8% in the semaglutide treatment group and 6.4% in the placebo group
Clayas goal as a telehealth provider is to provide a cost-effective, convenient alternative with accessible pricing, all-inclusive care from a team of experts, and comprehensive holistic lifestyle support
Novo Nordisk (NOVO.B DKK 876.70 CO) GLP-1 Evolutionary COMPANY OVERVIEW Headquartered in Bagsvrd, Denmark, Novo Nordisk develops and manufactures pharmaceutical products and services, with a focus on diabetes, obesity, and other serious chronic diseases including rare blood and endocrine diseases
US$ 23.72
US$ 22.77
US$ 23.47
US$ 24.59
US$ 28.12
US$ 23.79
